DE602004005455D1 - Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin - Google Patents

Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin

Info

Publication number
DE602004005455D1
DE602004005455D1 DE602004005455T DE602004005455T DE602004005455D1 DE 602004005455 D1 DE602004005455 D1 DE 602004005455D1 DE 602004005455 T DE602004005455 T DE 602004005455T DE 602004005455 T DE602004005455 T DE 602004005455T DE 602004005455 D1 DE602004005455 D1 DE 602004005455D1
Authority
DE
Germany
Prior art keywords
chronic wounds
leucine
glycin
treating
food composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004005455T
Other languages
English (en)
Other versions
DE602004005455T2 (de
Inventor
Wendeline Wouters-Wesseling
Lisette Wilhelmina Wagenaar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33462161&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004005455(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of DE602004005455D1 publication Critical patent/DE602004005455D1/de
Application granted granted Critical
Publication of DE602004005455T2 publication Critical patent/DE602004005455T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE602004005455T 2003-05-22 2004-05-19 Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin Expired - Lifetime DE602004005455T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03076556 2003-05-22
EP03076556 2003-05-22
PCT/NL2004/000355 WO2004103383A1 (en) 2003-05-22 2004-05-19 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein

Publications (2)

Publication Number Publication Date
DE602004005455D1 true DE602004005455D1 (de) 2007-05-03
DE602004005455T2 DE602004005455T2 (de) 2007-11-29

Family

ID=33462161

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004005455T Expired - Lifetime DE602004005455T2 (de) 2003-05-22 2004-05-19 Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin

Country Status (11)

Country Link
US (1) US20070042019A1 (de)
EP (1) EP1633377B1 (de)
JP (1) JP2007500208A (de)
CN (1) CN100448453C (de)
AT (1) ATE357241T1 (de)
AU (1) AU2004241884B2 (de)
BR (1) BRPI0410761A (de)
CA (1) CA2526349A1 (de)
DE (1) DE602004005455T2 (de)
ES (1) ES2282880T3 (de)
WO (1) WO2004103383A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1780562B (zh) * 2004-01-14 2011-04-13 味之素株式会社 含甘氨酸食品及其应用
RU2449554C2 (ru) 2006-02-01 2012-05-10 Нестек С.А. Пищевые системы и способы увеличения долголетия
MY148276A (en) * 2006-10-19 2013-03-29 Nestec Sa Long-term feed- elderly
AU2007312216B2 (en) * 2006-10-19 2011-03-31 Nestec S.A. Long-term feed - cancer patient
JP5221094B2 (ja) * 2007-09-28 2013-06-26 テルモ株式会社 褥瘡患部の皮下筋層の再生剤
CA2778647A1 (en) * 2009-11-25 2011-06-03 Nestec S.A. Nutritional compositions including a high protein component and exogenous nucleotides
BR112012033422B8 (pt) * 2010-06-28 2021-05-11 Nestec Sa formulação de alimentação por sonda de alimentação diária completa, seu uso e seu método de fabricação
CN103431277B (zh) * 2013-08-31 2014-08-27 山东卫康生物医药科技有限公司 一种供创伤、手术患者食用的五谷杂粮全营养配方食品
ITMI20131660A1 (it) 2013-10-08 2015-04-09 Professional Dietetics Srl Uso di una combinazione per la prevenzione delle mucositi indotte da radiazioni o da chemioterapici
WO2018091566A1 (en) * 2016-11-16 2018-05-24 Fresenius Kabi Deutschland Gmbh Nutritional composition for use in therapy of patients with copd, neurological diseases or disorders and/or wounds
DE102018124227A1 (de) 2018-10-01 2020-04-02 sanaFactur GmbH Zubereitung zur Verbesserung körpereigener Wundheilung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025650A (en) * 1975-11-24 1977-05-24 Control Drug, Inc. Method and composition for preventing nutritional deficiency
US4112123A (en) * 1976-07-21 1978-09-05 Beatrice Foods Co. Nutritionally balanced single food composition and method of production
US4780475A (en) * 1986-02-03 1988-10-25 Cerra Frank B Preparation for the prevention of catabolism
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
JP4011638B2 (ja) * 1994-12-27 2007-11-21 イーエヌ大塚製薬株式会社 経口経腸栄養組成物
US5656608B1 (en) * 1995-02-23 2000-09-26 Novartis Nutrition Ltd Amino acid compositions and methods of treatment using same
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
JPH11130669A (ja) * 1997-10-28 1999-05-18 Ajinomoto Co Inc 褥瘡予防治療用アミノ酸栄養剤
EP0960572A1 (de) * 1998-05-12 1999-12-01 N.V. Nutricia Ernährungszusammensetzung zur Behandlung von Dekubitalgeschwüren
CN1126541C (zh) * 1999-12-03 2003-11-05 中国人民解放军军事医学科学院放射医学研究所 新型复合氨基酸组合物
CN1423528A (zh) * 2000-04-18 2003-06-11 雀巢制品公司 营养单元
DE20101225U1 (de) * 2001-01-24 2001-06-13 Sportmedizin Team Vertriebs Gm Präparat für hohe körperliche Beanspruchung

Also Published As

Publication number Publication date
AU2004241884B2 (en) 2009-07-30
ES2282880T3 (es) 2007-10-16
BRPI0410761A (pt) 2006-06-27
CN1809367A (zh) 2006-07-26
CN100448453C (zh) 2009-01-07
JP2007500208A (ja) 2007-01-11
DE602004005455T2 (de) 2007-11-29
EP1633377B1 (de) 2007-03-21
US20070042019A1 (en) 2007-02-22
AU2004241884A2 (en) 2004-12-02
AU2004241884A1 (en) 2004-12-02
EP1633377A1 (de) 2006-03-15
WO2004103383A1 (en) 2004-12-02
CA2526349A1 (en) 2004-12-02
ATE357241T1 (de) 2007-04-15

Similar Documents

Publication Publication Date Title
MXPA05011886A (es) Metodos y composiciones para la prevencion y tratamiento de septicemia.
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
ATE326239T1 (de) Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
DE60222670D1 (de) Orale zusammesetzung zur vorbeugung oder behandlung von sepsis
BRPI0410972C1 (pt) método para aumentar a vida de armazenagem de uma composição farmacêutica, composição farmacêutica, e, método para tratamento de hiperglicemia
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
NO20042151L (no) Sammensetning for a forbedre skjelettvekst og opprettholdelse av benhelse
DE60001914D1 (de) Mehrzweck zusammensetzungen von säuren
MX349188B (es) Sns - 595 y metodos para utilizar el mismo.
BR0313282A (pt) Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia
MY140132A (en) Thiazolidin-4-one derivatives for use in the treatment of anemias
DE602004005455D1 (de) Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin
NO20060498L (no) Metode for a promotere benvekst
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
BG102619A (en) Substituted n-[(aminoiminomethyl or aminomethyl) phenyl] propylamides
DE60327557D1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
EA200800397A1 (ru) Композиции тизанидина и способы лечения с применением композиций
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
ATE397453T1 (de) Zusammensetzung zur behandlung und/oder vorbeugung von insulinresistenz
DE69902520D1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
DE50207740D1 (de) Verwendung von phosphatidylserin zur behandlung des aufmerksamkeits-defizit-syndroms (adhs)
ATE486612T1 (de) Verfahren zur behandlung von diabetes typ 2
WO2004058268A3 (de) Verwendung von tetrahydrobiopterinderivaten zur behandlung und ernährung von patienten mit aminosäurestoffwechselstörungen

Legal Events

Date Code Title Description
8363 Opposition against the patent